Efficacy and mechanism of Shugan Jieyu combined with sertraline in alcohol-dependent patients with depression: A randomized clinical study

舍曲林 医学 内科学 萧条(经济学) 抗抑郁药 哈姆德 不利影响 随机对照试验 汉密尔顿抑郁量表 心情 评定量表 重性抑郁障碍 临床试验 临床研究 联合疗法 治疗组和对照组 治疗效果 临床疗效 抑郁症状 安慰剂 入射(几何) 药物治疗 显著性差异
作者
Yan Zhang,Hao-Yu-xing,Juan Yan
出处
期刊:World journal of psychiatry [Baishideng Publishing Group]
卷期号:15 (12)
标识
DOI:10.5498/wjp.v15.i12.111801
摘要

BACKGROUND Proper antidepressant use can improve mood and reduce desire to drink alcohol in alcohol-induced-affective-disorder patients. Shugan Jieyu capsules (SJC) have various impacts on the central nervous system, producing antidepressant effects. Traditional Chinese medicine (including Shugan Jieyu) is highly therapeutic in treating alcohol dependence, with few side-effects. However, research on its combination with Western antidepressants (e.g., sertraline) to improve patients’ depression is insufficient. AIM To evaluate the clinical efficacy and safety of SJC combined with sertraline vs sertraline monotherapy in alcohol-dependent patients with comorbid depression. METHODS We conducted a randomized, double-blind, placebo-controlled trial. Sixty patients (aged 18-65 years) were randomly assigned to two groups (n = 30 per group). Primary outcome: Hamilton Depression Rating Scale (HAMD)-17 changes over 6 weeks. Benzodiazepines were permitted for severe insomnia. RESULTS The HAMD-17 score of the study (vs control) group was lower at treatment weeks 2, 4, and 6 (P < 0.05). Regarding intra-group comparisons, the study group’s HAMD score was significantly lower than that before treatment from week 2 (P < 0.05), while that of the control group was significantly lower than that before treatment from week 4 (P < 0.05). The study and control groups’ total efficacy rates were 90% and 73.3%, respectively, showing a significant difference in efficacy (χ² = 4.812, P = 0.028). No significant difference was observed in adverse reactions’ incidence between the groups at treatment weeks 2, 4, and 6 (P > 0.05). CONCLUSION SJC-sertraline combination therapy accelerates depressive symptom relief (by 2 weeks) and improves response rates (+16.7%) in alcohol-dependent patients, without increasing adverse events. Clinical outcomes suggest potential synergistic mechanisms, though no biomarker analyses were performed.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Gaojuan完成签到,获得积分10
1秒前
自由的如波完成签到,获得积分10
1秒前
zxy发布了新的文献求助10
1秒前
想要文章完成签到,获得积分10
2秒前
2秒前
刘洋发布了新的文献求助10
3秒前
所所应助凶狠的幻柏采纳,获得10
3秒前
3秒前
酷波er应助lei采纳,获得10
3秒前
3秒前
3秒前
4秒前
hmv发布了新的文献求助150
5秒前
刘可心关注了科研通微信公众号
6秒前
小蘑菇应助大宝君采纳,获得10
6秒前
6秒前
沉默的凌雪完成签到 ,获得积分10
7秒前
nico完成签到 ,获得积分10
7秒前
SciGPT应助钱烨华采纳,获得10
8秒前
好吃完成签到 ,获得积分10
8秒前
F_ken发布了新的文献求助10
9秒前
9秒前
9秒前
kingmantj发布了新的文献求助10
10秒前
10秒前
etuuuuuu发布了新的文献求助10
10秒前
钢铁侠完成签到,获得积分10
11秒前
xnzll完成签到,获得积分10
12秒前
俭朴依白发布了新的文献求助10
12秒前
12秒前
Jian完成签到 ,获得积分10
13秒前
yy发布了新的文献求助10
15秒前
xnzll发布了新的文献求助10
15秒前
15秒前
16秒前
科研通AI6.2应助Ekko采纳,获得10
16秒前
科研通AI6.2应助耍酷绮采纳,获得10
17秒前
在水一方应助dxy采纳,获得10
18秒前
刘志萍完成签到 ,获得积分10
19秒前
想要文章发布了新的文献求助10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Introduction to Helicopter and Tiltrotor Flight Simulation, Second Edition 2500
卤化钙钛矿人工突触的研究 2000
Malcolm Fraser : a biography 700
Signals, Systems, and Signal Processing 610
Software that combines deep learning,3D reconstruction and CFD to analyze the state of carotid arteries from ultrasound imaging 600
Bounds for Statistical Estimation in Semiparametric Models 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6500454
求助须知:如何正确求助?哪些是违规求助? 8295576
关于积分的说明 17704193
捐赠科研通 5597243
什么是DOI,文献DOI怎么找? 2918355
邀请新用户注册赠送积分活动 1895414
关于科研通互助平台的介绍 1756310